QCM
ABBV icon

Qsemble Capital Management’s AbbVie ABBV Stock Holding History

Qsemble Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,100
Closed -$3.55M – 438
2025
Q2 		$3.55M Sell
19,100
-16,089
-46% -$2.99M 0.34% 97
2025
Q1 		$7.37M Buy
+35,189
New +$6.84M 0.78% 24
2024
Q2 		– Sell
-29,762
Closed -$5.42M – 406
2024
Q1 		$5.42M Buy
+29,762
New +$5.13M 1.18% 2
2023
Q4 		– Sell
-13,100
Closed -$1.95M – 336
2023
Q3 		$1.95M Buy
13,100
+900
+7% +$132K 0.37% 97
2023
Q2 		$1.64M Buy
+12,200
New +$1.79M 1.17% 13
2023
Q1 		– Sell
-5,000
Closed -$808K – 229
2022
Q4 		$808K Buy
+5,000
New +$767K 0.56% 62

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qsemble Capital Management's ABBV Position: Q3 2025 in Review

Qsemble Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 19,100 shares — an estimated $3.55M sold.

Qsemble Capital Management first reported a position in ABBV in Q4 2022 and held it in 6 quarters. The position peaked at $7.37M in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Qsemble Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 19,100 AbbVie shares in Q3 2025, an estimated $3.55M.
  • Qsemble Capital Management first reported a position in AbbVie in Q4 2022 and held it in 6 quarters.
  • Qsemble Capital Management's AbbVie position peaked at $7.37M in Q1 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Qsemble Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.